Bank of America’s BioCardia BCDA Stock Holding History
Bought
Maintained
Sold
Other funds holding BCDA
CM
PP
XT
VF
Bank of America's BCDA Position: Q1 2026 in Review
Bank of America sold out of BioCardia (BCDA) in Q1 2026, closing a stake of 469 shares — an estimated $587 sold.
Bank of America first reported a position in BCDA in Q2 2020 and held it in 23 quarters. The position peaked at $25K in Q1 2021. 18 funds tracked by Wall St. Rank hold BCDA as of Q1 2026.
- Bank of America reported no remaining BioCardia position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 469 BioCardia shares in Q1 2026, an estimated $587.
- Bank of America first reported a position in BioCardia in Q2 2020 and held it in 23 quarters.
- Bank of America's BioCardia position peaked at $25K in Q1 2021.
- 18 funds tracked by Wall St. Rank held BioCardia as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.